CompletedPhase 2

RMP-A03 Ocular Suspension in Patients With Pterygium

United States77 participantsStarted 2023-06-09

Plain-language summary

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must be at least 18 years old * Diagnosis of pterygium with specified characteristics * BCVA of 20/200 or better * Willingness to attend all study visits and comply with the study procedures Exclusion Criteria: * Presence of ocular disease * Double pterygium * History of ocular surgery * Presence of ocular trauma * Use of any ocular medication * Use of contact lens * Allergy to any of the components of study drug * Cannot properly administer study drug * Clinically significant systemic disease that may place the subject at risk or confound study results * Participation in an investigational study within 30 days prior to screening * Female participants who are pregnant, nursing, planning a pregnancy, or not using a medically acceptable form of birth control (WOCBP).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change From Baseline in Pterygium Hyperemia Grading at Day 28

Timeframe: 28 days

Trial details

NCT IDNCT05794204

SponsorSuzhou Raymon Pharmaceuticals Company, Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-01-12

Results submitted2026-04-16

View on ClinicalTrials.gov More Pterygium trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.